The focus of the symposium will be on Immuno-Oncology with the following international speakers. Inger Andersson, Chairman of IVA’s Biotechnology – Introduction Professor Kjell Strandberg, former DG MPA – What is immune oncology? Magnus Jäderberg, CMO Targovax, London – The new cancer drugs in a clinical perspective Professor Peter Nygren, Department of Oncology, University Hospital, Uppsala – Faster approvals […]